Details for New Drug Application (NDA): 012125
✉ Email this page to a colleague
NDA 012125 describes CARBOCAINE W/ NEO-COBEFRIN, which is a drug marketed by Eastman Kodak and is included in one NDA. Additional details are available on the CARBOCAINE W/ NEO-COBEFRIN profile page.
The generic ingredient in CARBOCAINE W/ NEO-COBEFRIN is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
The generic ingredient in CARBOCAINE W/ NEO-COBEFRIN is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for 012125
| Tradename: | CARBOCAINE W/ NEO-COBEFRIN |
| Applicant: | Eastman Kodak |
| Ingredient: | levonordefrin; mepivacaine hydrochloride |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.05MG/ML;2% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
